A novel role for TGF-β and IL-10 in the induction of immune privilege

Journal of Immunology

Volumn 160, Issue 5, 1998, Pages 2089-2098

  D'Orazio, Thomas J ^a   Niederkorn, Jerry Y ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN SPECIFICITY; ARTICLE; CELL DIFFERENTIATION; DELAYED HYPERSENSITIVITY; DISEASE PREDISPOSITION; DOWN REGULATION; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION;

ANIMALS; ANTERIOR CHAMBER; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CYTOKINES; IMMUNITY, CELLULAR; INTERLEUKIN-10; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0032030582     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17:138.
2. Gajewski, T. F., and F. W. Fitch. 1988. Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol. 140:4245.
3. Fiorentino, D. F., M. W. Bond, and T. R. Mosmann. 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081.
4. Sadick, M. D., R. M. Locksley, C. Tubbs, and K. V. Raff. 1986. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-γ in response to Leishmania antigens in vitro. J. Immunol. 136:655.
5. Scott, P., P. Natovitz, R. L. Coffman, E. Pearce, and A. Sher. 1988. Immunoregulation of cutaneous leishmaniasis: T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 168:1675.
6. Locksley, R. M., F. P. Heinzel, M. D. Sadick, B. J. Holaday, and K. D. Gardner, Jr. 1987. Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T-cell subsets. Ann. Inst. Pasteur Immunol. 138:744.
7. + T-cell subset differentiation. Res. Immunol. 142:36.
8. Streilein, J. W. 1993. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr. Opin. Immunol. 5:428.
9. Meyers, R. L., and T. H. Pettit. 1975. Pathogenesis of experimental allergic uveitis induced by retinal rod outer segments and pigment epithelium. J. Immunol. 114:1269.
10. Atherton, S. S., G. A. Pesicka, and J. W. Streilein. 1987. Retinitis and deviant immune responses following intravitreal inoculation of HSV-1. Invest. Ophthalmol. Vis. Sci. 28:859.
11. Niederkorn, J. Y., and P. C. Meunier. 1985. Spontaneous immune rejection of intraocular tumors in mice. Invest. Ophthalmol. Vis. Sci. 26:877.
12. Niederkorn, J. Y., and J. W. Streilein. 1983. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses. J. Immunol. 131:2670.
13. Niederkorn, J. Y. 1990. Immune privilege and immune regulation in the eye. Adv. Immunol. 48:191.
14. Streilein, J. W., B. R. Ksander, and A. W. Taylor. 1997. Immune deviation in relation to ocular immune privilege. J. Immunol. 158:3557.
15. Ferguson, T. A., and T. S. Griffith. 1997. A vision of cell death: insights into immune privilege. Immunol. Rev. 156:167.
16. Streilein, J. W., G. A. Wilbanks, and S. W. Cousins. 1992. Immunoregulatory mechanisms of the eye. J. Neuroimmunol. 39:185.
17. Griffith, T. S., X. Yu, J. M. Herndon, D. R. Green, and T. A. Ferguson. 1996. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 5:7.
18. Li, X. Y., T. J. D'Orazio, and J. Y. Niederkorn. 1996. Role of Th1 and Th2 cells in anterior chamber-associated immune deviation. Immunology 89:34.
19. Benson, J. L., and J. Y. Niederkom. 1991. In situ suppression of delayed-type hypersensitivity: another mechanism for sustaining the immune privilege of the anterior chamber. Immunology 74:153.
20. Knisely, T. L., M. W. Luckenbach, B. J. Fischer, and J. Y. Niederkom. 1987. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors. J. Immunol. 138:4515.
21. Niederkom, J. Y., and T. L. Knisely. 1988. Immunological analysis of a destructive pattern of intraocular tumor resolution. Curr. Eye Res. 7:515.
22. Knisely, T. L., and J. Y. Niederkom. 1990. Immunologic evaluation of spontaneous regression of an intraocular murine melanoma. Invest. Ophthalmol. Vis. Sci. 31:247.
23. Niederkom, J. Y. 1991. The immunopathology of intraocular tumour rejection. Eye 5:186.
24. Niederkom, J. Y., J. L. Benson, and E. Mayhew. 1990. Efferent blockade of delayed-type hypersensitivity responses in the anterior chamber of the eye. Reg. Immunol. 3:349.
25. Ma, D., S. Comerford, D. Bellingham, J. Sambrook, M. J. Gething, H. Alizadeh, R. Anand, J. Mellon, and J. Y. Niederkom. 1994. Capacity of simian virus 40 T antigen to induce self-tolerance but not immunological privilege in the anterior chamber of the eye. Transplantation 57:718.
26. Kielty, D., S. W. Cousins, and S. S. Atherton. 1987. HSV-1 retinitis and delayed hypersensitivity in DBA/2 and C57BL/6 mice. Invest. Ophihalmol. Vis. Sci. 28: 1994.
27. Wilbanks, G. A., M. Mammolenti, and J. W. Streilein. 1992. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta. Eur. J. Immunol. 22:165.
28. Wilbanks, G. A., and J. W. Streilein. 1992. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta. Eur. J. Immunol. 22:1031.
29. Mosmann, T. R., and K. W. Moore. 1991. The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol. Today 12:A49.
30. Trinchieri, G. 1993. Interleukin-12 and its role in the generation of TH1 cells. Immunol. Today 14:335.
31. Kuhn, R., K. Rajewsky, and W. Muller. 1991. Generation and analysis of interleukin-4 deficient mice. Science 254:707.
32. Kuhn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263.
33. Niederkom, J., J. W. Streilein, and J. A. Shadduck. 1981. Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice. Invest. Ophthalmol. Vis. Sci. 20:355.
34. + T cells. Annu. Rev. Immunol. 12:635.
35. Thompson, C. B. 1995. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 81:979.
36. + cells at the site of antigen deposition predicts the development of a T helper 2 cell response to Schistosoma mansoni eggs. J. Immunol. 155:4844.
37. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
38. Hauser, C. 1990. Cultured epidermal Langerhans cells activate effector T cells for contact sensitivity. J. Invest. Dermatol. 95:436.
39. + T cells. J. Immunol. 154:5071.
40. + T cells to produce IL-4. J. Immunol. 158:4171.
41. Reiner, S. L., and R. A. Seder. 1995. T helper cell differentiation in immune response. Curr. Opin. Immunol. 7:360.
42. Go, N. F., B. E. Castle, R. Barren, R. Kastelein, W. Dang, T. R. Mosmann, K. W. Moore, and M. Howard. 1990. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exp. Med. 172:1625.
43. De Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
44. Trinchieri, G., and P. Scott. 1994. The role of interleukin 12 in the immune response, disease and therapy. Immunol. Today 15:460.
45. DAndrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (FL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041.
46. DAndrea, A., X. Ma, M. Aste-Amezaga, C. Paganin, and G. Trinchieri. 1995. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production. J. Exp. Med. 181:537.
47. Enk, A. H., and S. I. Katz. 1992. Identification and induction of keratinocyte-derived IL-10. J. Immunol. 149:92.
48. Thompson-Snipes, L., V. Dhar, M. W. Bond, T. R. Mosmann, K. W. Moore, and D. M. Rennick. 1991. Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J. Exp. Med. 173:507.
49. Ferguson, T. A., P. Dube, and T. S. Griffith. 1994. Regulation of contact hypersensitivity by interleukin 10. J. Exp. Med. 179:1597.
50. Cua, D. J., R. L. Coffman, and S. A. Stohlman. 1996. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function. J. Immunol. 157:2830.
51. Granstein, R. D., R. Staszewski, T. L. Knisely, E. Zeira, R. Nazareno, M. Latina, and D. M. Albert. 1990. Aqueous humor contains transforming growth factor-β and a small (less than 3500 daltons) inhibitor of thymocyte proliferation. [Published erratum appears in 1991 J. Immunol. 146:3687.] J. Immunol. 144:3021.
52. Jiang, L. Q., and J. W. Streilein. 1991. Immune privilege extended to allogeneic tumor cells in the vitreous cavity. Invest. Ophthalmol. Vis. Sci. 32:224.
53. Fabry, Z., D. J. Topham, D. Fee, J. Herlein, J. A. Carlino, M. N. Hart, and S. Sriram. 1995. TGF-β2 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system in vivo. J. Immunol. 155:325.
54. Pollanen, P., M. von Euler, K. Jahnukainen, T. Saari, M. Parvinen, S. Sainio-Pollanen, and O. Soder. 1993. Role of transforming growth factor beta in testicular immunosuppression. J. Reprod. Immunol. 24:123.
55. Chambaz, E. M., S. Souchelnitskiy, S. Pellerin, G. Defaye, C. Cochet, and J. J. Feige. 1996. Transforming growth factors-beta s: a multifunctional cytokine family: implication in the regulation of adrenocortical cell endocrine functions. Horm. Res. 45:222.
56. Ferguson, T. A., Y. Gao, J. M. Herndon, and T. S. Griffith. 1997. Apoptotic cell death and TL-10 production in the eye are essential for the induction of immune deviation. Invest. Ophthalmol. Vis. Sci. 38:5492.